EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strategies for Modifying Adenoviral Vectors for Gene Therapy

Anna Muravyeva iD, Svetlana Smirnikhina

International Journal of Molecular Sciences · 20.11.2024 · 25 (22) · 12461

DOI: 10.3390/ijms252212461 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.11.2024. Verfasst von Anna Muravyeva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia. Hauptthemen laut MEDLINE: Genetic Vectors, Genetic Therapy, Adenoviridae. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenoviral vectors (AdVs) are effective vectors for gene therapy due to their broad tropism, large capacity, and high transduction efficiency, making them widely used as oncolytic vectors and for creating vector-based vaccines. This review also considers the application of adenoviral vectors in oncolytic virotherapy and gene therapy for inherited diseases, analyzing strategies to enhance their efficacy and specificity. However, despite significant progress in this field, the use of adenoviral vectors is limited by their high immunogenicity, low specificity to certain cell types, and limited duration of transgene expression. Various strategies and technologies aimed at improving the characteristics of adenoviral vectors are being developed to overcome these limitations. Significant attention is being paid to the creation of tissue-specific promoters, which allow for the controlled expression of transgenes, as well as capsid modifications that enhance tropism to target cells, which also play a key role in reducing immunogenicity and increasing the efficiency of gene delivery. This review focuses on modern approaches to adenoviral vector modifications made to enhance their effectiveness in gene therapy, analyzing the current achievements, challenges, and prospects for applying these technologies in clinical practice, as well as identifying future research directions necessary for successful clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic VectorsGenetic TherapyAdenoviridaeHumansAnimalsOncolytic VirotherapyTransgenesGene Transfer TechniquesPromoter Regions, Genetic

Stichwörter der Autor:innen

adenoviral vectorscapsid modificationscystic fibrosisgene therapyimmunogenicityinherited diseasesornithine transcarbamylase deficiencytissue-specific promoterstropism

Autor:innen und Institutionen

  • Laboratory of Genome Editing, Research Centre for Medical Genetics, Moskvorechye, 1, 115522 Moscow, Russia.

ORCID-Profile: Anna Muravyeva

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Muravyeva, A., & Smirnikhina, S. (2024). Strategies for Modifying Adenoviral Vectors for Gene Therapy. International Journal of Molecular Sciences, 25(22), 12461. https://doi.org/10.3390/ijms252212461

Vancouver

Muravyeva A, Smirnikhina S. Strategies for Modifying Adenoviral Vectors for Gene Therapy. International Journal of Molecular Sciences. 2024;25(22):12461. doi:10.3390/ijms252212461

BibTeX
@article{Muravyeva2024,
  author = {Muravyeva, Anna and Smirnikhina, Svetlana},
  title = {Strategies for Modifying Adenoviral Vectors for Gene Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {22},
  pages = {12461},
  doi = {10.3390/ijms252212461}
}
Kostenlos starten →